Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-10
1988-03-15
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546146, 546147, 546174, 546175, 546332, 546335, 546336, 546337, 546339, 546342, 544224, 548204, 548214, 548236, 548247, 548341, 514247, 514307, 514311, 514357, 514358, 514372, 514374, 514378, 514399, C07D21304, C07D27730, A61K 3144, A61K 31425
Patent
active
047313730
ABSTRACT:
Glycerine derivatives of the formula ##STR1## wherein the residues R.sup.1, R.sup.2 and R.sup.3 have the significance given in the description,
and their hydrates, which inhibit blood platelet activating factor (PAF), are descried.
REFERENCES:
patent: 3686238 (1972-08-01), Zaffaroal
patent: 4137317 (1979-01-01), Paris et al.
Chemical Abstracts 84: 10536f (1976).
Derwent 32,738.
Derwent 83-797365.
Derwent 21692S
Derwent 33708K
Derwent 84-079212
Barner Richard
Burri Kasper
Cassal Jean-Marie
Hadvary Paul
Hirth Georges
Bjorkman Dale A.
Hoffman-La Roche Inc.
Isgro William G.
Jiles Henry R.
Leon Bernard S.
LandOfFree
Glycerin derivatives and inhibition of blood PAF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycerin derivatives and inhibition of blood PAF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycerin derivatives and inhibition of blood PAF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1926689